Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Structure Therapeutics Inc (GPCR)

Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,830,728
  • Shares Outstanding, K 46,619
  • Annual Sales, $ 0 K
  • Annual Income, $ -89,620 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.33
Trade GPCR with:

Options Overview Details

View History
  • Implied Volatility 69.16% ( -5.75%)
  • Historical Volatility 137.91%
  • IV Percentile 12%
  • IV Rank 5.66%
  • IV High 224.41% on 05/31/24
  • IV Low 59.84% on 03/20/24
  • Put/Call Vol Ratio 1.15
  • Today's Volume 380
  • Volume Avg (30-Day) 1,837
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 25,895
  • Open Int (30-Day) 29,580

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.23
  • Number of Estimates 4
  • High Estimate -0.20
  • Low Estimate -0.24
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.56 +17.01%
on 06/03/24
62.74 -37.41%
on 06/03/24
+2.19 (+5.91%)
since 05/28/24
3-Month
33.56 +17.01%
on 06/03/24
62.74 -37.41%
on 06/03/24
-3.59 (-8.38%)
since 03/28/24
52-Week
25.57 +53.58%
on 08/17/23
75.02 -47.65%
on 11/01/23
+0.22 (+0.56%)
since 06/28/23

Most Recent Stories

More News
Could Structure Therapeutics Become the Next Novo Nordisk?

Becoming the next Novo Nordisk is a long shot, but it's more likely than it sounds.

GPCR : 39.27 (+0.33%)
NVO : 142.74 (-1.21%)
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?

Analysts who follow the start-up drugmaker think its stock has a chance to soar, but that doesn't mean it's right for you.

GPCR : 39.27 (+0.33%)
NVO : 142.74 (-1.21%)
LLY : 905.38 (-0.40%)
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?

Structure Therapeutics has a long way to go before beating Wegovy.

LLY : 905.38 (-0.40%)
GPCR : 39.27 (+0.33%)
NVO : 142.74 (-1.21%)
Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

With weight-loss drugs gaining traction, which biopharma stock wins?

NVO : 142.74 (-1.21%)
LLY : 905.38 (-0.40%)
GPCR : 39.27 (+0.33%)
VKTX : 53.01 (+4.41%)
$SPX : 5,460.48 (-0.41%)
$IUXX : 19,682.87 (-0.54%)
JPM : 202.26 (+1.55%)
This Weight-Loss Stock Could Surge 75%, Says JPMorgan

Structure Therapeutics is a clinical-stage weight-loss company that is poised to gain traction in a rapidly expanding addressable market.

NVO : 142.74 (-1.21%)
LLY : 905.38 (-0.40%)
GPCR : 39.27 (+0.33%)
JPM : 202.26 (+1.55%)
Analysts Expect This 'Strong Buy' Weight-Loss Stock to Double

Structure Therapeutics is developing an oral weight-loss drug, which could allow it to gain traction in a rapidly expanding addressable market.

GPCR : 39.27 (+0.33%)
NVO : 142.74 (-1.21%)
LLY : 905.38 (-0.40%)
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now

It has genuine struggles ahead, but it has some actual value in hand as well.

PFE : 27.98 (+0.65%)
GPCR : 39.27 (+0.33%)
LLY : 905.38 (-0.40%)
2 Biotech Stocks That Could Soar in December

These two biotechs have important catalysts coming up in December.

BLUE : 0.9842 (+3.74%)
GPCR : 39.27 (+0.33%)
Should You Still Buy the Nasdaq's Best-Performing October Stocks?

Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.

COMP : 3.60 (-2.44%)
GPCR : 39.27 (+0.33%)
IBRX : 6.32 (-3.36%)
OLK : 25.48 (+0.75%)
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

PTN : 1.9500 (+2.63%)
RYTM : 41.06 (+2.32%)
VKTX : 53.01 (+4.41%)
GPCR : 39.27 (+0.33%)
NVO : 142.74 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 41.89
2nd Resistance Point 40.61
1st Resistance Point 39.94
Last Price 39.27
1st Support Level 37.99
2nd Support Level 36.71
3rd Support Level 36.04

See More

52-Week High 75.02
Fibonacci 61.8% 56.13
Fibonacci 50% 50.29
Fibonacci 38.2% 44.46
Last Price 39.27
52-Week Low 25.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar